Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Zevra Therapeutics (ZVRA) Shares Repurchased (2021 - 2023)

Zevra Therapeutics (ZVRA) has disclosed Shares Repurchased for 3 consecutive years, with $3.4 million as the latest value for Q1 2023.

  • For the quarter ending Q1 2023, Shares Repurchased changed N/A year-over-year to $3.4 million, compared with a TTM value of $3.4 million through Dec 2023, down 27.02%, and an annual FY2023 reading of $3.4 million, down 27.02% over the prior year.
  • Shares Repurchased was $3.4 million for Q1 2023 at Zevra Therapeutics, down from $4.7 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $4.7 million in Q2 2022 and bottomed at $2.8 million in Q4 2021.
  • Average Shares Repurchased over 3 years is $3.7 million, with a median of $3.4 million recorded in 2023.